Aquestive therapeutics to present positive data from pharmacokinetic and pharmacodynamic studies for anaphylm™ at american college of allergy asthma and immunology (acaai) annual meeting

Warren, n.j., nov. 10, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that two posters recapping the positive data from pharmacokinetic (pk) and pharmacodynamic (pd) pre-clinical and clinical studies of anaphylm™ (epinephrine) sublingual film will be presented at the american college of allergy asthma and immunology (acaai) annual meeting, which will be held from november 9-13 in anaheim, california.
AQST Ratings Summary
AQST Quant Ranking